AstraZeneca (LON:AZN) Receives “Buy” Rating from Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to investors on Monday,Digital Look reports. The brokerage currently has a GBX 140 ($1.75) target price on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports on AZN. JPMorgan Chase & […]

Leave a Reply

Your email address will not be published.

Previous post New Orleans attack came at a time of political heat, and transition, for the FBI
Next post Regent Peak Wealth Advisors LLC Trims Position in Kemper Co. (NYSE:KMPR)